Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhimin Shao

Showing results (101-110 of 203) with videos related to

Pageof 21
Sort By:
Breast Cancer Research and Treatment|December 3, 2013
Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapyMinhao Fan, Jian Zhang, Zhonghua Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2018
Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancerJohn F R Robertson, Kwok-Leung Cheung, Shinzaburo Noguchi, et al.
Breast (Edinburgh, Scotland)|September 12, 2022
Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysisYuting Sang, Benlong Yang, Miao Mo, et al.
Breast Cancer Research and Treatment|April 6, 2011
FOXC1, a target of polycomb, inhibits metastasis of breast cancer cellsJuan Du, Lin Li, Zhouluo Ou, et al.
Oncotarget|May 2, 2015
Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancerXiaoqing Jia, Qi Hong, Li Lei, et al.
Plos One|March 14, 2015
Phase II study of Pseudomonas aeruginosa-Mannose-Sensitive hemagglutinin in combination with capecitabine for Her-2-negative metastatic breast cancer pretreated with anthracycline and taxaneFangfang Lv, Jun Cao, Zhebin Liu, et al.
Scientific Reports|January 16, 2020
The prognostic and predictive potential of Ki-67 in triple-negative breast cancerXiuzhi Zhu, Li Chen, Binhao Huang, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|February 18, 2014
Adjuvant chemotherapy increases the prevalence of fat necrosis in immediate free abdominal flap breast reconstructionLin Li, Ying Chen, Jiaying Chen, et al.
Nanomaterials (Basel, Switzerland)|June 11, 2026
Boosting the Performance of Visible/Near-Infrared Organic Photodetectors via Hole Interface EngineeringYijing Fan, Junquan Luo, Lan Liu, et al.
Frontiers in Genetics|December 6, 2021
A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant ChemotherapyBingqing Xia, He Wang, Zhe Wang, et al.
Pageof 21

Showing results (101-110 of 203) with videos related to

Sort By:
Pageof 21
Breast Cancer Research and Treatment|December 3, 2013
Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapyMinhao Fan, Jian Zhang, Zhonghua Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2018
Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancerJohn F R Robertson, Kwok-Leung Cheung, Shinzaburo Noguchi, et al.
Breast (Edinburgh, Scotland)|September 12, 2022
Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysisYuting Sang, Benlong Yang, Miao Mo, et al.
Breast Cancer Research and Treatment|April 6, 2011
FOXC1, a target of polycomb, inhibits metastasis of breast cancer cellsJuan Du, Lin Li, Zhouluo Ou, et al.
Oncotarget|May 2, 2015
Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancerXiaoqing Jia, Qi Hong, Li Lei, et al.
Plos One|March 14, 2015
Phase II study of Pseudomonas aeruginosa-Mannose-Sensitive hemagglutinin in combination with capecitabine for Her-2-negative metastatic breast cancer pretreated with anthracycline and taxaneFangfang Lv, Jun Cao, Zhebin Liu, et al.
Scientific Reports|January 16, 2020
The prognostic and predictive potential of Ki-67 in triple-negative breast cancerXiuzhi Zhu, Li Chen, Binhao Huang, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|February 18, 2014
Adjuvant chemotherapy increases the prevalence of fat necrosis in immediate free abdominal flap breast reconstructionLin Li, Ying Chen, Jiaying Chen, et al.
Nanomaterials (Basel, Switzerland)|June 11, 2026
Boosting the Performance of Visible/Near-Infrared Organic Photodetectors via Hole Interface EngineeringYijing Fan, Junquan Luo, Lan Liu, et al.
Frontiers in Genetics|December 6, 2021
A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant ChemotherapyBingqing Xia, He Wang, Zhe Wang, et al.
Pageof 21